AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

OCTA in Cardiovascular Disease and Healthy Controls

RecruitingNAAges 18 Years - 75 YearsAllUniversity of Erlangen-Nรผrnberg Medical School
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria for patients with cardiovascular disease: * cardiovascular disease defined as one or more of the following: arterial hypertension, type 2 diabetes mellitus, chronic kidney disease, heart failure Inclusion Criteria for healthy individuals: * BMI 18-29.9 kg/m2 * Non-smoker * Good general health, as determined by study personnel based on assessments of previous visits, including anamnesis, vital signs, physical examination and clinical laboratory parameters. Exclusion criteria for patients with cardiovascular disease: * Active ophthalmological (retinal) disease resulting in impaired visual assessment of retinal vessels (e.g. glaucoma, cataracts, retinal oedema). Exclusion criteria for healthy individuals: * Active ophthalmological (retinal) disease with reduced visual assessment of retinal vessels (e.g. glaucoma, cataracts, retinal oedema). * clinically relevant deviation in physical examination, vital signs, or laboratory parameters (based on the physician's clinical judgement). * a clinically relevant history of cardiovascular disease or any other previously known cardiovascular disease * History of clinically relevant neurological, gastrointestinal, renal, hepatic, psychological, pulmonary, metabolic, endocrine or other diseases * office blood pressure above or equal to 140/90 mmHg * Office heart rate outside of the following range: 50-99 bpm * regular intake of any medication for the treatment of cardiovascular diseases (e.g. antihypertensive or antidiabetic medication) within one month before study inclusion * alcohol or drug abuse
๐Ÿ’Š

What it tests

  • Retinal vascular assessment using OCTA and SLDF
๐Ÿ“

Where

1 site
University of Erlangen Nuremberg
Erlangen, Germany
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy